On 25 November 2025, Sanofi entered into a share purchase agreement to sell a 70% stake in the company operating its Lüleburgaz pharmaceutical manufacturing facility to Fareva, a world leader in industrial subcontracting for the pharmaceuticals, cosmetics, and industrial & household sectors. Sanofi will retain a 30% minority stake in the company.
The Lüleburgaz facility is one of Türkiye’s leading pharmaceutical manufacturing sites, with significant production capacity and export capabilities. The transaction is expected to close upon completion of customary regulatory approvals, including clearance from the Turkish Competition Authority.
Paksoy is pleased to announce that a team consisting of partner Stéphanie Beghe Sönmez, along with counsel Zeynep Toma and associates Selen Toma and Cansın Taner, is acting as counsel to Sanofi on this transaction.
Share
Related persons
You can contact us for detailed information.



Legal Information
This briefing is for information purposes; it is not legal advice. If you have questions, please call us. All rights reserved.
You May Be Interested In
29 July 2026
Paksoy advises Azimut on the acquisition of Yapı Kredi Portföy, one of Türkiye’s leading asset management companies
On 29 July 2026, Azimut, a leading international asset management group, entered into a share purchase agreement to acquire approximately…
14 July 2026
Emre Kotil and Emre Açıkgöz contributed to the Türkiye Chapter of the AI Justice Atlas
As Türkiye's Grand National Assembly AI Research Commission's landmark report enters the public debate, the conversation around AI in…
13 July 2026
We are recognised in the Mergermarket 2026 H1 EMEA Legal Advisory Rankings
We are pleased to be recognised once again in the Mergermarket 2026 H1 EMEA Legal Advisory Rankings, maintaining our position among the…
2 July 2026
We are pleased to announce that Tuba Yeşil joined Paksoy’s Antitrust and Competition practice from the Turkish Competition Authority.
We are pleased to announce that Tuba Yeşil joined Paksoy’s Antitrust and Competition practice from the Turkish Competition Authority.
15 June 2026
We have been named Türkiye’s National Law Firm of the Year at the IFLR Europe Awards 2026
Paksoy has been named Türkiye's National Law Firm of the Year at the IFLR Europe Awards 2026 - for the sixth time in the past eight……
1 June 2026
CEE Legal Matters named CVC’s Investment in Dream Games Deal of the Year for Türkiye
We are proud to have advised CVC on its investment in Dream Games, which has been named “Deal of the Year for Türkiye” at the CEE Legal…
